TOKYO, April 1 /PRNewswire/ -- Bausch & Lomb Japan has named Mitsuo (Mike) Hirose as chairman, effective immediately. Mr. Hirose has served on the subsidiary's Board of Directors since January 2009.
Mr. Hirose brings exceptional executive experience to Bausch & Lomb Japan, complementing the company's existing leadership team. Most recently he was representative director and chairman of Pacific Golf Group International Holdings KK. Prior roles included serving as president of Dai Nippon Printing Company's U.S. operations, and as a founder of corporate governance and ethics consultancy Maverick Japan Inc.
In addition, Mr. Hirose brings with him considerable depth in healthcare management. He has served as president and representative director for both Johnson & Johnson Japan Inc. and Johnson & Johnson Medical Company, as well as in other capacities for the Johnson & Johnson Group of Companies. He was responsible for introducing disposable contact lenses to the Japanese market, and was a committee member of Central Social Insurance Medical Council, Health, Labor, and Welfare Ministry until 2005.
Mr. Hirose graduated from the Department of Political Science, Faculty of Law,
"We look forward to working with Hirose-san, and believe that our customers and partners, as well as everyone at Bausch & Lomb Japan, will benefit from his insights and guidance," said Gerald M. Ostrov, chairman and chief executive officer, Bausch & Lomb.
Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for people around the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.
|SOURCE Bausch & Lomb|
Copyright©2009 PR Newswire.
All rights reserved